Australia’s trusted immunisation experts
02 November 2022 | NewsAt least two thirds of Australians, including children and adolescents, have had COVID-19, two national antibody studies findRead the full article
The first Australian Technical Advisory Group on Immunisation (ATAGI) 2021 Annual Statement on Immunisation has been published in the Communicable Diseases Intelligence journal. It is the first publication in this series.
The statement highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases (VPDs) in Australia in 2020. The statement also signals ATAGI’s priority actions for addressing key issues for 2021 and beyond.
In 2020, many immunisation issues were shaped by the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 control measures contributed to lower rates of many VPDs in Australia. Preparation also began for Australia’s COVID-19 immunisation program, which commenced in February 2021.
Read the full statement here
NCIRS provides scientific research support to ATAGI, particularly for the development and implementation of national immunisation policies. NCIRS conducts research, and reviews and synthesises the best available evidence to support ATAGI to formulate advice and clinical recommendations on immunisations.